FFCP PHASE1:Hg19::chr2:232326643..232326648,-
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p16@NCL |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_16_at_NCL_5end |
| Coexpression cluster: | C483_acute_diffuse_medulloblastoma_hepatocellular_small_mesothelioma_testicular |
| Association with transcript: | -248bp_to_AK001314_5end |
| EntrezGene: | NCL |
| HGNC: | 7667 |
| UniProt: | B3KM80 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p16@NCL |
|---|
0
2
4
6
8
10
12
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| disease of cellular proliferation | 4.47e-22 | 239 |
| cancer | 1.61e-21 | 235 |
| cell type cancer | 6.51e-12 | 143 |
| carcinoma | 2.01e-11 | 106 |
| hematologic cancer | 8.90e-11 | 51 |
| immune system cancer | 8.90e-11 | 51 |
| leukemia | 1.57e-10 | 39 |
| myeloid leukemia | 5.31e-08 | 31 |
| organ system cancer | 7.84e-08 | 137 |
Showing 1 to 9 of 9 entries
